FDA Clearance For Hemodynamic Monitor

Whippany, NJ - Medcon Telemedicine Technology, Inc. announced that it received U.S. Food and Drug Administration clearance for its new hemodynamic monitoring system, Windsurfer. Windsurfer is marketed and sold separately, or together with Medcon's TCS Symphony image management solution for integration of cardiac images and data in the cath lab.

"The market has witnessed a transformation in hemodynamic systems - they have gone from basic monitoring systems to integral parts of the complete catheterization process," says Uzi Blumensohn, CEO Medcon Telemedicine Technology, Inc. "Significant portions of procedural data, as well as workflow procedures, are controlled by the hemodynamic monitoring system. That's why it was a natural decision for Medcon to expand our current product offering to include Windsurfer, a new and powerful hemodynamic monitoring system. Windsurfer streamlines the cath lab workflow and aggregates all data into one cardiac electronic medical record, complimenting our existing image and information management solution."

The Windsurfer hemodynamic monitoring system uses cutting-edge technology to deliver a solution with flexibility for personalized configuration that melds into the complex cath lab workflow.

The functionality and graphic interface of Windsurfer were designed with the help of a steering committee consisting of healthcare professionals. This approach to product development helped Medcon design an application that is truly intuitive to use, and addresses the most common issues encountered in the actual working environment.

"Time and again our customers tell us that one of their favorite Medcon software applications is our reporting tool, and Windsurfer further strengthens our report application," continues Blumensohn. "Waveforms, hemodynamic data and procedural data are automatically populated into the final procedure report."

SOURCE: Medcon Telemedicine Technology